Provenienza dei contatti di primo grado di Todd Curtis
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
18
| Subsidiary | Pharmaceuticals: Major | 18 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Todd Curtis tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| EDITAS MEDICINE, INC. | Biotechnology | Chief Executive Officer Director/Board Member Director/Board Member | |
| BIOGEN INC. | Pharmaceuticals: Major | General Counsel Corporate Officer/Principal Corporate Officer/Principal | |
| IDENIX PHARMACEUTICALS INC | Pharmaceuticals: Major | Director of Finance/CFO General Counsel | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
| AMAG PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Chief Executive Officer | |
KalVista Pharmaceuticals Ltd.
 KalVista Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology KalVista Pharmaceuticals Ltd. develops novel plasma kallikrein inhibitors. It also engages in the development of serine protease inhibitors and novel plasma kallikrein inhibitors represent a, approach to the treatment of DME, a leading cause of adult visual loss, plasma kallikrein inhibitors target a distinct molecular pathway and as such have the potential to offer those patients an effective treatment option. The firm has a clinical and advanced pre-clinical product pipeline targeting both intravitreal injection and oral administration, and its plasma kallikrein inhibitors can be applied to additional indications in ophthalmology. The company was founded by Lloyd Paul Aiello, Andrew Crockett, Robert Haigh and Edward P. Feener in 2011 and is headquartered in Porton Down, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| KALVISTA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
New England Venture Capital Association, Inc.
 New England Venture Capital Association, Inc. Miscellaneous Commercial ServicesCommercial Services New England Venture Capital Association, Inc. is a non-profit organization which operates as a catalyst, and advocate, and a resource for the innovation economy. The company is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Atlas Venture Advisors, Inc.
 Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor Private Equity Investor | |
| University of London | College/University | Doctorate Degree | |
| Isabella Stewart Gardner Museum | Consultant / Advisor | ||
Judo Bio, Inc.
 Judo Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Judo Bio, Inc. operates as a biotechnology company. The company is based in Cambridge, MA. The company was founded in 2021 by Chelsea Place Johnson. | Miscellaneous Commercial Services | Director/Board Member | |
Atlas Venture Life Science Advisors LLC
 Atlas Venture Life Science Advisors LLC Investment ManagersFinance Atlas Venture Life Science Advisors LLC (Atlas Venture) is a venture capital firm founded in 2014. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor | |
| ALNYLAM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Cardiff University School of Medicine | College/University | Doctorate Degree | |
| The Royal College of Physicians | College/University | Corporate Officer/Principal | |
| DISC MEDICINE, INC. | Biotechnology | Director/Board Member | |
| SCHOLAR ROCK HOLDING CORPORATION | Biotechnology | Director/Board Member | |
Scholar Rock, Inc.
 Scholar Rock, Inc. BiotechnologyHealth Technology Scholar Rock, Inc. operates as a biotechnology company. It focuses on discovering and developing a novel class of biologic therapies that target supracellular activation of growth factors in the disease microenvironment. The company was founded by Timothy Springer and Leonard Zon and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
| University of Cardiff | College/University | Undergraduate Degree | |
Cempra Pharmaceuticals, Inc.
 Cempra Pharmaceuticals, Inc. BiotechnologyHealth Technology Cempra Pharmaceuticals, Inc. develops medicines for treating drug-resistant bacterial infections. The firm's antibacterial products, both in clinical trials, address the urgent and increasing need for new treatments targeting drug-resistant bacterial infections in both the hospital and the community. The company was founded by Prabhavathi B. Fernandes IN 2006 and is headquartered in Chapel Hill, NC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| University of Maryland School of Medicine | College/University | Doctorate Degree | |
| Morphic Rock LLC | Corporate Officer/Principal | ||
Chroma Medicine, Inc.
 Chroma Medicine, Inc. Pharmaceuticals: MajorHealth Technology Chroma Medicine, Inc. is a biotechnology company that pioneers a new class of genomic medicines using epigenetics to deliver precise, programmable single-dose therapeutics while preserving genomic integrity. The company is based in Cambridge, MA and has subsidiaries in Italy. The company's modular platform enables the development of medicines that can address a wide range of complex diseases, whether they require silencing, activation, or targeting multiple genes at once. Chroma Medicine was founded by the world's foremost experts in genomic research and is led by a veteran team of industry leaders and scientists with deep experience in genomic medicine, drug discovery, and development. Catherine Stehman-Breen has been the CEO of the company since 2020. | Pharmaceuticals: Major | Director/Board Member | |
| Epacing, Inc. | Director/Board Member | ||
| GENOCEA BIOSCIENCES, INC. | Biotechnology | Founder | |
| NEURONETICS, INC. | Medical Specialties | Director/Board Member | |
| KALA BIO, INC. | Pharmaceuticals: Major | Director/Board Member | |
| Harvard Medical School | College/University | Doctorate Degree | |
InSeal Medical Ltd.
 InSeal Medical Ltd. Medical SpecialtiesHealth Technology InSeal Medical Ltd. engages in developing and manufacturing of percutaneous vascular closure devices. The company was founded by Avi Penner and is headquartered in Caesarea, Israel. | Medical Specialties | Director/Board Member | |
Direct Vet Marketing, Inc.
 Direct Vet Marketing, Inc. Information Technology ServicesTechnology Services Direct Vet Marketing, Inc. provides cloud-based prescription management, pharmacy services, marketing solutions and practice analytics for equine and companion animal veterinary practitioners. It offers online ordering and home delivery of prescription drugs, compounded medications, and therapeutic diets. The company was founded by David Evans Shaw and Benjamin J. Shaw in 2010 and is headquartered in Portland, Maine. | Information Technology Services | Director/Board Member | |
Morphic Therapeutic, Inc.
 Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | Biotechnology | Chief Executive Officer | |
KSQ Therapeutics, Inc.
 KSQ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology KSQ Therapeutics, Inc. develops and deploys precision functional genomics to discover therapies that transform patient lives. The company was founded by Tim Wang and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member | |
Mariana Oncology, Inc.
 Mariana Oncology, Inc. BiotechnologyHealth Technology Mariana Oncology, Inc., also known as Curie Therapeutics, is a radiopharmaceuticals company that specializes in developing safe and effective targeted radiopharmaceuticals for cancer treatment. The company is based in Woburn, MA and was founded by Simon Read, who has been the CEO since incorporation. The company's radiopharmaceuticals are designed to deliver alpha and beta-emitting radionuclide payloads to carefully selected biological targets. | Biotechnology | Director/Board Member | |
| MORPHIC HOLDING, INC. | Pharmaceuticals: Major | Director/Board Member | |
| AKERO THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Navitor Pharmaceuticals, Inc.
 Navitor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Navitor Pharmaceuticals, Inc. develops medicine for age-related diseases. Its drug discovery platform targets mTORC1, which responds to and integrates the cell’s response to nutrient availability and plays a key role in protein synthesis and cellular growth. The company was founded by Alan L. Crane, David Sabatini and David Goldfarb and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member | |
ZappRx, Inc.
 ZappRx, Inc. Miscellaneous Commercial ServicesCommercial Services ZappRx, Inc. develops prescription and prior authorization platform services. It provides healthcare providers, specialty pharmacies, biopharmacies, and security standards solutions. The company was founded by Zoe Barry in 2012 and is headquartered in Boston, MA. | Miscellaneous Commercial Services | Director/Board Member | |
Kinaset Therapeutics, Inc.
 Kinaset Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Kinaset Therapeutics, Inc. engages in the provision of pharmaceutical services. It develops therapeutics for intractable diseases including severe asthma. The company was founded by Robert Clarke, Roger Heerman, and Frazer Morgan and is headquartered in Medfield, MA. | Pharmaceuticals: Major | Director/Board Member | |
Novartis Optogenetics Research, Inc.
 Novartis Optogenetics Research, Inc. BiotechnologyHealth Technology Vedere Bio, Inc. develops cutting-edge gene therapy products to restore functional vision to patients who have suffered vision loss. The company was founded in June 2019 and is headquartered in Cambridge, MA. | Biotechnology | Chairman | |
Remix Therapeutics, Inc.
 Remix Therapeutics, Inc. BiotechnologyHealth Technology Remix Therapeutics, Inc. operates as a biotechnology company. It involves in developing small molecule therapies which are designed to reprogram RNA processing to address the underlying drivers of disease. The company was founded by Pete Smith and is headquartered in Cambridge, MA. | Biotechnology | Founder | |
Vedere Bio II, Inc.
 Vedere Bio II, Inc. Miscellaneous Commercial ServicesCommercial Services Vedere Bio II, Inc. develops ocular gene therapy. The company is based in Cambridge, MA. The company was founded by Cyrus D. Mozayeni. Cyrus D. Mozayeni has been the CEO since incorporation. | Miscellaneous Commercial Services | Director/Board Member | |
Prism Venture Management LLC
 Prism Venture Management LLC Investment ManagersFinance Prism Venture Management LLC (Prism Venture Management) is a venture capital firm founded in 1996 by Bob C. Fleming and John L. Brooks. The firm is headquartered in Needham, Massachusetts. | Investment Managers | Private Equity Investor | |
| Williams College | College/University | Undergraduate Degree | |
| The Johns Hopkins University | College/University | Undergraduate Degree | |
| PEPGEN INC. | Biotechnology | Director/Board Member |
Statistiche
Distribuzione geografica
| Stati Uniti | 45 |
| Regno Unito | 6 |
| Israele | 2 |
Settori
| Health Technology | 31 |
| Consumer Services | 10 |
| Commercial Services | 5 |
| Finance | 4 |
| Technology Services | 2 |
Posizioni
| Director/Board Member | 119 |
| Independent Dir/Board Member | 25 |
| Corporate Officer/Principal | 16 |
| Chairman | 14 |
| Undergraduate Degree | 13 |
Contatti più connessi
| Insiders | |
|---|---|
| Joshua Resnick | 36 |
| Kevin Bitterman | 36 |
| Steven Holtzman | 28 |
| Brian Pereira | 23 |
| David Arkowitz | 20 |
| Robert McQuade | 14 |
| Bernadette Connaughton | 10 |
| Akshay Vaishnaw | 10 |
| John F. Weidenbruch | 9 |
| Elham Hershberger | 5 |
| Zachary Shriver | 4 |
| David Oldach | 4 |
| Chris Kiefer | 1 |
| Harren Jhoti | 1 |
| Toshiki Sudo | 1 |
- Borsa valori
- Insiders
- Todd Curtis
- Connessioni Società
